0001493152-22-017510.txt : 20220622
0001493152-22-017510.hdr.sgml : 20220622
20220622170059
ACCESSION NUMBER: 0001493152-22-017510
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220621
FILED AS OF DATE: 20220622
DATE AS OF CHANGE: 20220622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Iwicki Mark T
CENTRAL INDEX KEY: 0001415537
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40544
FILM NUMBER: 221032723
MAIL ADDRESS:
STREET 1: 84 WATERFORD DRIVE
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc.
CENTRAL INDEX KEY: 0001798749
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831377888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: FLOOR 18
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-443-2400
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: FLOOR 18
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
ownership.xml
X0306
4
2022-06-21
0
0001798749
Aerovate Therapeutics, Inc.
AVTE
0001415537
Iwicki Mark T
C/O AEROVATE THERAPEUTICS, INC.
930 WINTER STREET, SUITE M-500
WALTHAM,
MA
02451
1
0
0
0
Stock Option (Right to Buy)
12.26
2022-06-21
4
A
0
12500
0
A
2032-06-20
Common Stock
12500
12500
D
The shares subject to this option will vest and become exercisable in full on the earlier of (i) June 21, 2023 or (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service through the applicable vesting date.
/s/ George A. Eldridge, Attorney-in-Fact
2022-06-22